Medical Device Company Updates MMSEA Section 111 Reporting Policy

North America - United States

A medical device company reviewed and updated its reporting policy for Section 111 of the Medicare, Medicaid and SCHIP Extension Act of 2007 (MMSEA). FaegreBD counseled the company during the review. FaegreBD confirmed the applicability of the Section 111 reporting requirements and reviewed the company's policies and procedures related to Section 111 reporting. As a result of the audit, certain changes were implemented to shore up the company's Section 111 compliance program.

The Faegre Baker Daniels website uses cookies to make your browsing experience as useful as possible. In order to have the full site experience, keep cookies enabled on your web browser. By browsing our site with cookies enabled, you are agreeing to their use. Review Faegre Baker Daniels' cookies information for more details.